Antigen-specific immunotherapy as a component of complex treatment for malignant tumors of the brain

Voprosy Onkologii

Volumn 49, Issue 2, 2003, Pages 170-175

  Ostanin, A A ^a   Centner, M I ^a   Khonina, N A ^a   Leplina, O Yu ^a   Shevela, Ye Yu ^a   Nikonov, S D ^a   Stupak, V V ^a   Chernykh, Ye R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HLA DR ANTIGEN; TUMOR ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; ASTROCYTOMA; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG TOLERABILITY; EVALUATION; EXTRACORPOREAL ANTIGEN SPECIFIC IMMUNOTHERAPY; GLIOBLASTOMA; HUMAN; IMMUNOSURVEILLANCE; LYMPHOCYTE COUNT; POSTOPERATIVE PERIOD; ADULT; BRAIN TUMOR; CLINICAL TRIAL; FEMALE; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PILOT STUDY; TREATMENT OUTCOME;

ADULT; ANTIGENS, NEOPLASM; ASTROCYTOMA; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 0037530345     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Davis F.G., Malinski N., Haenzel W. et al. Primary brain tumor incidence rates in four United States regions, 1985-1989: a pilot study // Neuroepidemiology (Switzerland). - 1996. - Vol. 15. - P. 103-112.
2. Rosenberg S.A. Immunotherapy of cancer using interleukin-2: current status and future prospects // Immunol. Today. - 1988. - Vol. 9. - P. 58-62.
3. Rosenberg S.A., Lotze M.T., Muul L.M. et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone // N. Engl. J. Med. - 1987. - Vol. 316. - P. 889-897.